SHARON HOOPER: Open Payments
NPI 1821387325 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 59 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,377
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $268 |
| ACADIA Pharmaceuticals Inc | 7 | $200 |
| UCB, Inc. | 5 | $110 |
| PFIZER INC. | 4 | $73 |
| Lilly USA, LLC | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ARGENX US, INC. | 2 | $67 |
| Mallinckrodt Hospital Products Inc. | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| TG Therapeutics, Inc. | 2 | $53 |
Products named: NUPLAZID, UBRELVY, QULIPTA, AMYVID, REXULTI, VYVGART HYTRULO, Fintepla, ACTHAR.
Industry payments across SC — which companies pay providers there.
